Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD

Authors:

Abstract
Increased levels of growth differentiation factor-15 (GDF15) are associated with cachexia, cardiovascular disease and all-cause mortality. The role of GDF15 in chronic obstructive pulmonary disease (COPD) is unknown.The study included 413 patients with COPD from the Bergen COPD Cohort Study. All patients had a forced expiratory volume in 1 s (FEV1) 1to forced vital capacity (FVC) ratio 1/FVC were evaluated with regression models.Median plasma GDF15 was 0.86 ng·mL−1(interquartile range 0.64–1.12 ng·mL−1). The distribution was not normal and GDF15 was analysed as a categorical variable. High levels of GDF15 were associated with a higher exacerbation rate (incidence rate ratio 1.39, 95% CI 1.1–1.74, p=0.006, adjusted values). Furthermore, high levels of GDF15 were associated with higher mortality (hazard ratio 2.07, 95% CI 1.4–3.1, p1(4.29%versus3.25%) and FVC (2.63%versus1.44%) in comparison to low levels (p1and FVC.

This publication has 39 references indexed in Scilit: